166 related articles for article (PubMed ID: 10144942)
1. New glutaraldehyde labeling controversial.
Patterson P
OR Manager; 1995 Sep; 11(9):26. PubMed ID: 10144942
[No Abstract] [Full Text] [Related]
2. Disinfection guidelines: the great debate.
Souhrada L
Mater Manag Health Care; 1997 Mar; 6(3):40, 42, 44. PubMed ID: 10165578
[No Abstract] [Full Text] [Related]
3. Glutaraldehyde sterilants: FDA vs. APIC soaking times.
Healthc Hazard Mater Manage; 1995 Jun; 8(9):1-2. PubMed ID: 10143314
[No Abstract] [Full Text] [Related]
4. Label fables: EPA cites hype in 'bugproof' products.
Blyth PL
Health Facil Manage; 1998 Sep; 11(9):54, 56-7. PubMed ID: 10182769
[No Abstract] [Full Text] [Related]
5. The dirt on disinfectants--do labels tell the truth?
Blyth PL
Health Facil Manage; 1997 Aug; 10(8):66, 68. PubMed ID: 10169069
[No Abstract] [Full Text] [Related]
6. The Sporicidin recall.
Healthc Hazard Mater Manage; 1992 Jan; 5(4):9-11. PubMed ID: 10116667
[TBL] [Abstract][Full Text] [Related]
7. Sporicidin responds to the recall of its products.
Healthc Hazard Mater Manage; 1992 Aug; 5(11):8-11. PubMed ID: 10121070
[TBL] [Abstract][Full Text] [Related]
8. Understanding US labelling requirements.
Donawa M
Med Device Technol; 2005 Sep; 16(7):21-3. PubMed ID: 16259155
[TBL] [Abstract][Full Text] [Related]
9. Tougher glutaraldehyde requirements: what CS technicians need to know.
Swenson D
Mater Manag Health Care; 1993 May; 2(5):36, 38-9. PubMed ID: 10125746
[No Abstract] [Full Text] [Related]
10. Regulating drug promotion on the Internet.
Bannon L
Food Drug Law J; 1999; 54(4):599-621. PubMed ID: 11824457
[No Abstract] [Full Text] [Related]
11. Tagging the issues surrounding auto-ID labels.
Sparnon E
Biomed Instrum Technol; 2006; Suppl():25-6. PubMed ID: 16596846
[No Abstract] [Full Text] [Related]
12. Sporicidin update: are the government's regulatory teeth tearing a hole in industry?
Healthc Hazard Mater Manage; 1993 Apr; 6(7):10-1. PubMed ID: 10125098
[No Abstract] [Full Text] [Related]
13. Education or promotion?: Industry-sponsored continuing medical education (CME) as a center for the core/commercial speech debate.
Chen P;
Food Drug Law J; 2003; 58(3):473-509. PubMed ID: 14626981
[No Abstract] [Full Text] [Related]
14. Prohibited acts and enforcement tools.
Mathewson NW
Food Drug Law J; 2010; 65(3):545-54. PubMed ID: 24479241
[No Abstract] [Full Text] [Related]
15. Fifty years of cosmetic safety: a government and industry partnership.
Donegan TJ
Food Drug Law J; 1995; 50 Spec():151-62. PubMed ID: 10343040
[No Abstract] [Full Text] [Related]
16. Gunning for glutaraldehyde. How one medical center gained control.
Souhrada L
Mater Manag Health Care; 1999 Mar; 8(3):44. PubMed ID: 10351578
[No Abstract] [Full Text] [Related]
17. Regulation of dietary supplement advertising: current claims of interest to the Federal Trade Commission, Food and Drug Administration and National Advertising Division.
Villafranco JE; Lustigman AB
Food Drug Law J; 2007; 62(4):709-25. PubMed ID: 18557227
[No Abstract] [Full Text] [Related]
18. Ambiguities of the Dietary Supplement Health and Education Act of 1994.
Pinco RG; Rubin PD
Food Drug Law J; 1996; 51(3):383-405. PubMed ID: 11797716
[No Abstract] [Full Text] [Related]
19. FDA notifications. Labeling rule proposed for dietary supplements.
AIDS Alert; 2003 Jul; 18(7):90-1. PubMed ID: 12846199
[No Abstract] [Full Text] [Related]
20. Ophthalmic drug products for over-the-counter human use; proposed amendment of final monograph--FDA. Proposed rule.
Fed Regist; 1998 Feb; 63(35):8888-90. PubMed ID: 10177740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
